Half-year report · Q2
3750.TEDINET S100US7P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥91m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥1.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥863m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥407m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥354m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥420m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥907m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥424m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥419m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥138m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥443m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥443m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥5.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.8bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.0bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥522m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥522m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥208m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥673m | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥421m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥367m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥8.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥102m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥94m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-48.42 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.47 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.65 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.42 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 41.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥144m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥65m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥65m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥206m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥27m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥27m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥57m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥91m |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥91m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥263m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | −¥87m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥45m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥45m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥285m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥818m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥818m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥863m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥863m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | −¥267m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 444
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人ハイビスカス | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)阿 部 海 輔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)福 田 健 太 郎 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 862531000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 91433000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1560388000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -423528000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -419631000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -906664000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -443334000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -432334000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 138155000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -442854000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -432570000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 139149000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 2213719000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 2338582000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2795586000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 13598409000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 5146718000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 5816334000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -49.65 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -48.42 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 15.47 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 15.42 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.147 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.413 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.443 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | -367057000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -420752000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -1152230000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -3492000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -4134000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | 8689978000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -94430000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -101591000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -7172572000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 208070000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 521986000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1038227000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8929419 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8929419 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 8929419 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 8929419 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 1153814 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1292 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |